BMC Anesthesiology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-07-30 ms6000000673439938 来自甘肃省

2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！

73 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-10-17 ms7000000580164983 来自山东省

别投，3周还是with editor

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-10-08 caoyanting2 来自北京

审稿速度:6.0
偏重的研究方向：临床麻醉
经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-03-12 inchina888999 来自浙江省

投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多

122 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-07-11 ms6000000673439938 来自甘肃省

2024中的第二篇，给各位同志分享一下时间线以供参考
Submission received 30 Apr 2024
Submission is under technical check 30 Apr 2024
Amendment requested 14 May 2024
Amendment received 14 May 2024
Submission passed technical check 25 May 2024
Ready for editorial assignment 25 May 2024
Editor assigned 25 May 2024
Submission under peer review 28 May 2024
Revision requested 28 Jun 2024
Revision received 02 Jul 2024
Submission accepted 11 Jul 2024

97 0

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-06-27 ms6000000673439938 来自甘肃省

投了一篇meta
Submission received 07 Mar 2024
Submission passed technical check 07 Mar 2024
Editor assigned 13 Mar 2024
Submission under peer review 13 Mar 2024
Revision received 27 May 2024
Submission accepted 27 Jun 2024
Submission is in publishing and rights 27 Jun 2024
优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。
缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-05-13 147dadaam95暂无昵称来自福建省

审稿周期长，半年多才一审回来。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-01-25 1468631587 来自四川省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床研究
经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！

122 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2023-11-20 bonnie-yh 来自广东省

审稿速度:6.0
经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。

111 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217603, encodeId=958f221e6036a, content=2024年投的第三篇，前两篇基本都是三个月左右接受，第三篇龟速。4.22投，5.10开始外审，官网显示5.17收到审稿人报告，但是一直还是peer review的状态。给编辑发了好几封邮件均石沉大海。有点无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Tue Jul 30 15:22:38 CST 2024, time=2024-07-30, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2231274, encodeId=cfd522312e4cc, content=别投，3周还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7a9138890, createdName=ms7000000580164983, createdTime=Thu Oct 17 06:20:12 CST 2024, time=2024-10-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2229828, encodeId=19f32229828de, content=审稿速度:6.0 偏重的研究方向：临床麻醉 经验分享：审稿特别特别慢，小修一次，之后又等了三个多月了，到现在啥消息也没有，据说是找不到审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec371560063, createdName=caoyanting2, createdTime=Tue Oct 08 15:44:11 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192762, encodeId=88f62192e6261, content= 投稿需要 provide a separate document detailing the trial protocol in the English language only? 这个怎么写，感觉要写好多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9bb51305814, createdName=inchina888999, createdTime=Tue Mar 12 14:43:07 CST 2024, time=2024-03-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214457, encodeId=c06e221445ecc, content=2024中的第二篇，给各位同志分享一下时间线以供参考 Submission received 30 Apr 2024 Submission is under technical check 30 Apr 2024 Amendment requested 14 May 2024 Amendment received 14 May 2024 Submission passed technical check 25 May 2024 Ready for editorial assignment 25 May 2024 Editor assigned 25 May 2024 Submission under peer review 28 May 2024 Revision requested 28 Jun 2024 Revision received 02 Jul 2024 Submission accepted 11 Jul 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jul 11 14:29:56 CST 2024, time=2024-07-11, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2211917, encodeId=2982221191ecc, content=投了一篇meta Submission received 07 Mar 2024 Submission passed technical check 07 Mar 2024 Editor assigned 13 Mar 2024 Submission under peer review 13 Mar 2024 Revision received 27 May 2024 Submission accepted 27 Jun 2024 Submission is in publishing and rights 27 Jun 2024 优点：英国老牌杂志，不算水刊，有一定认可度，编辑也比较友好，审稿人也比较负责，提的意见还算中肯，对meta友好。 缺点：BMC出了名的比较墨迹，编辑回邮件有的时候间隔时间很长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Thu Jun 27 11:47:20 CST 2024, time=2024-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2204336, encodeId=9178220433690, content=审稿周期长，半年多才一审回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1455249596, createdName=147dadaam95暂无昵称, createdTime=Mon May 13 00:17:14 CST 2024, time=2024-05-13, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2183976, encodeId=856821839e6c6, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究 经验分享：投稿到接收不到4个月，挺顺利，一审小修，二审后直接接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96494708137, createdName=1468631587, createdTime=Thu Jan 25 22:03:29 CST 2024, time=2024-01-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169625, encodeId=2ebc2169625d4, content=审稿速度:6.0 经验分享：现在审稿很墨迹，非常墨迹，得写几次催稿信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/p4eiaaeyWK5jaz5mPZiclWDxjXuM9aLBsbvyksLkRSTu03YPasOw7rxzqWvqVv5dPaZtV9pviatTnSIibmyXqMLzog/0, createdBy=2d701415129, createdName=bonnie-yh, createdTime=Mon Nov 20 08:54:20 CST 2023, time=2023-11-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181125, encodeId=4b41218112518, content=偏重的研究方向：临床麻醉 经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Sat Jan 13 09:43:17 CST 2024, time=2024-01-13, status=1, ipAttribution=)]

2024-01-13 594624370

偏重的研究方向：临床麻醉
经验分享：外审结束了，waiting for decision已经两周了。写信也不回，啥情况？

111 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务